[HTML][HTML] Elevation of MMP-9 levels promotes epileptogenesis after traumatic brain injury
B Pijet, M Stefaniuk, A Kostrzewska-Ksiezyk… - Molecular …, 2018 - Springer
Posttraumatic epilepsy (PTE) is a recurrent seizure disorder that often develops secondary
to traumatic brain injury (TBI) that is caused by an external mechanical force. Recent …
to traumatic brain injury (TBI) that is caused by an external mechanical force. Recent …
Matrix metalloproteinase‐3 in the central nervous system: a look on the bright side
I Van Hove, K Lemmens, S Van de Velde… - Journal of …, 2012 - Wiley Online Library
Matrix metalloproteinases (MMP s) are a large family of proteases involved in many cell‐
matrix and cell‐cell signalling processes through activation, inactivation or release of …
matrix and cell‐cell signalling processes through activation, inactivation or release of …
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia
Results of recent studies reveal vascular and neuroprotective effects of matrix
metalloproteinase-9 (MMP-9) inhibition and MMP-9 gene deletion in experimental stroke …
metalloproteinase-9 (MMP-9) inhibition and MMP-9 gene deletion in experimental stroke …
Altered neuronal architecture and plasticity in the visual cortex of adult MMP-3-deficient mice
J Aerts, J Nys, L Moons, TT Hu, L Arckens - Brain Structure and Function, 2015 - Springer
Abstract Matrix metalloproteinases (MMPs) are Zn 2+-dependent endopeptidases
considered to be essential for normal brain development and neuroplasticity by modulating …
considered to be essential for normal brain development and neuroplasticity by modulating …
Oxidized low‐density lipoprotein induces matrix metalloproteinase‐9 expression via a p42/p44 and JNK‐dependent AP‐1 pathway in brain astrocytes
Upregulation of matrix metalloproteinases (MMPs), especially MMP‐9, by oxidized low‐
density lipoprotein (oxLDL) is implicated in many inflammatory diseases including brain …
density lipoprotein (oxLDL) is implicated in many inflammatory diseases including brain …
Amyloid β oligomers disrupt blood–CSF barrier integrity by activating matrix metalloproteinases
The blood–CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE)
cells that maintain CNS homeostasis by producing CSF and restricting the passage of …
cells that maintain CNS homeostasis by producing CSF and restricting the passage of …
[HTML][HTML] PM2. 5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of …
BR Wang, JQ Shi, NN Ge, Z Ou, YY Tian… - Journal of …, 2018 - Springer
Background Numerous studies suggested that PM2. 5 exposure was associated with
increased risk of Alzheimer's disease (AD). But the precise mechanisms by which PM2. 5 …
increased risk of Alzheimer's disease (AD). But the precise mechanisms by which PM2. 5 …
Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease
NKH Lim, VL Villemagne, CPW Soon… - Journal of …, 2011 - content.iospress.com
Pathological changes in the Alzheimer's disease (AD) brain include amyoid-β (Aβ) plaques,
and neurofibrillary tangles, as well as neuronal death and synaptic loss. Matrix …
and neurofibrillary tangles, as well as neuronal death and synaptic loss. Matrix …
The role of matrix metalloproteinase-9 in dementia
N Helbecque, X Hermant, D Cottel, P Amouyel - Neuroscience letters, 2003 - Elsevier
Neurofibrillary tangles and senile plaques, constituted of extracellular amyloid deposits (Aβ),
are the two defining pathological hallmarks of Alzheimer's disease (AD). Inhibiting the …
are the two defining pathological hallmarks of Alzheimer's disease (AD). Inhibiting the …
LMP2 inhibitors as a potential treatment for Alzheimer's Disease
The immunoproteasome (iP), an inducible proteasome variant harboring three
immunosubunits, low molecular mass polypeptide-2 (LMP2), multicatalytic endopeptidase …
immunosubunits, low molecular mass polypeptide-2 (LMP2), multicatalytic endopeptidase …